CompaniesOrigo Biopharma

Origo Biopharma

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

81

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
Today
NCT04933565
Hover over trial bars to see details

Recent Trials

NCT04933565Lead Sponsor
First in Human Study of ORG-129 in Healthy Volunteers
PHASE1Completed
81 participants
Started: Jun 1, 2021 · Completed: Jan 9, 2023
Related Companies
Agomab
acquired